GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,002,000 | -0.1% | 551,400 | 0.0% | 0.02% | +16.7% |
| Q1 2022 | $24,019,000 | -1.2% | 551,400 | 0.0% | 0.02% | +5.9% |
| Q4 2021 | $24,317,000 | +15.4% | 551,400 | 0.0% | 0.02% | +13.3% |
| Q3 2021 | $21,069,000 | -4.0% | 551,400 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $21,957,000 | +10.0% | 551,400 | -1.4% | 0.02% | +7.1% |
| Q1 2021 | $19,961,000 | -3.0% | 559,300 | 0.0% | 0.01% | -6.7% |
| Q4 2020 | $20,582,000 | -2.2% | 559,300 | 0.0% | 0.02% | -11.8% |
| Q3 2020 | $21,052,000 | -7.7% | 559,300 | 0.0% | 0.02% | -15.0% |
| Q2 2020 | $22,814,000 | +7.7% | 559,300 | 0.0% | 0.02% | -4.8% |
| Q1 2020 | $21,192,000 | -19.4% | 559,300 | 0.0% | 0.02% | +10.5% |
| Q4 2019 | $26,282,000 | +9.5% | 559,300 | -0.6% | 0.02% | 0.0% |
| Q3 2019 | $24,007,000 | +6.2% | 562,500 | -0.4% | 0.02% | +11.8% |
| Q2 2019 | $22,595,000 | -6.3% | 564,600 | -2.1% | 0.02% | -5.6% |
| Q1 2019 | $24,109,000 | +9.4% | 576,900 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $22,043,000 | -35.0% | 576,900 | -31.6% | 0.02% | -21.7% |
| Q3 2018 | $33,889,000 | -19.7% | 843,635 | -19.5% | 0.02% | -25.8% |
| Q2 2018 | $42,222,000 | +3.2% | 1,047,435 | 0.0% | 0.03% | 0.0% |
| Q1 2018 | $40,923,000 | +7.6% | 1,047,435 | -2.3% | 0.03% | +6.9% |
| Q4 2017 | $38,043,000 | -12.9% | 1,072,535 | -0.3% | 0.03% | -19.4% |
| Q3 2017 | $43,667,000 | -5.8% | 1,075,535 | 0.0% | 0.04% | -10.0% |
| Q2 2017 | $46,377,000 | +0.6% | 1,075,535 | -1.7% | 0.04% | -4.8% |
| Q1 2017 | $46,122,000 | +9.5% | 1,093,985 | 0.0% | 0.04% | +2.4% |
| Q4 2016 | $42,129,000 | -11.9% | 1,093,985 | -1.4% | 0.04% | -14.6% |
| Q3 2016 | $47,835,000 | -1.1% | 1,109,085 | -0.6% | 0.05% | -5.9% |
| Q2 2016 | $48,367,000 | +6.8% | 1,115,985 | -0.1% | 0.05% | +8.5% |
| Q1 2016 | $45,290,000 | -73.6% | 1,116,885 | -73.7% | 0.05% | -73.1% |
| Q4 2015 | $171,499,000 | +4.6% | 4,250,285 | -0.4% | 0.18% | -3.8% |
| Q3 2015 | $164,004,000 | -14.3% | 4,265,385 | -7.2% | 0.18% | -3.2% |
| Q2 2015 | $191,398,000 | -9.8% | 4,595,385 | -0.1% | 0.19% | -9.2% |
| Q1 2015 | $212,195,000 | +1.9% | 4,597,935 | -5.6% | 0.21% | -1.9% |
| Q4 2014 | $208,282,000 | -7.1% | 4,873,235 | -0.0% | 0.21% | -12.1% |
| Q3 2014 | $224,087,000 | -18.7% | 4,874,635 | -5.5% | 0.24% | -20.5% |
| Q2 2014 | $275,767,000 | -43.8% | 5,156,449 | -43.8% | 0.30% | -45.6% |
| Q1 2014 | $490,374,000 | -8.1% | 9,177,877 | -8.2% | 0.56% | -13.6% |
| Q4 2013 | $533,840,000 | +5.6% | 9,998,877 | -0.8% | 0.64% | -3.5% |
| Q3 2013 | $505,646,000 | -0.1% | 10,078,655 | -0.5% | 0.66% | -8.1% |
| Q2 2013 | $505,989,000 | – | 10,125,855 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |